top of page


deepCDR is an award-winning and active member of the Swiss Biotech startup community, find out what's currently happening in our news section


Learn about the science behind deepCDRs proprietary antibody discovery and optimization platform


deepCDR announces collaboration with Twist Bioscience

Sept. 22, 2021

We are excited to announce our new collaboration with Twist Bioscience on Deep Learning enabled Antibody Library Design. Together we've designed and built fully human naïve synthetic antibody libraries, including a new coronavirus-specific library, to add to their ever-growing Library of Libraries.

Twist Bioscience Press Release

deepCDR will be at Swiss Biotech Day 07.09.2021!

Sept. 7, 2021

deepCDR will be represented at 'Venture Leaders Biotech 2021' talk, 'Emerging Biotech Companies – Technologies' session, and the 'Artificial intelligence, machine learning and automation – impact in life sciences today and in the future' panel discussion!

SwissBiotech Day 2021 Program

deepCDR is representing Switzerland on the global stage!

July. 14, 2021

A jury of 60 investors and experienced biotech experts have selected deepCDR as one of the Venture Leaders Biotech 2021. We will join the Swiss National Startup Team and attend the VentureLab Roadshow in Boston (USA) in October 2021 and represent Switzerland as a strong biotech nation!

VentureLab Announcement 

deepCDR - Winners of IMD competition 2020!

Jan. 1, 2021

deepCDR wins the opportunity to work with IMD’s Executive MBA cohort in 2021, accompanying them to Silicon Valley in September and November, and support as the Executive MBAs pitch deepCDR to Silicon Valley VCs!

Press Release

deepCDR - Winners of Venture Kick 2020!

Aug. 24, 2020

deepCDR wins 150k CHF through the 2020 edition of VentureLab's Venture Kick competition

Press Release

bottom of page